Business News

Equities Jump as S&P 500, Nasdaq Hit Record Highs After Powell’s Upbeat Economic View

Equities Jump as S&P 500, Nasdaq Hit Record Highs After Powell’s Upbeat Economic View

Equities pushed higher on Friday with the Standard & Poor’s 500 and the Nasdaq Composite hitting new record highs after Federal Reserve Chairman Jerome Powell reiterated the outlook for “gradual” rate hikes and offered an upbeat view of the world’s biggest economy. The monetary policy boss said in the annual economic symposium in Jackson Hole, Wyoming that the US economy […]

Juniper Networks Downgraded to Market Perform

Juniper Networks Downgraded to Market Perform

Juniper Networks (JNPR) received an investment-rating downgrade and price-target cut from BMO Capital Markets despite the network-technologies company’s late-Thursday report of better-than-expected Q2 results, as its guidance for Q3 came in below Street views. BMO now has an investment rating of market perform on Juniper’s shares, down from outperform. Its new price target from BMO is $27 per share, down […]

Amazon’s Potential Move Into Data Center Switches Has Negative Consequences for Nokia

Amazon’s Potential Move Into Data Center Switches Has Negative Consequences for Nokia

JPMorgan said that Amazon’s (AMZN) AWS unit may move into data center switches which has negative consequences for Nokia’s foray into the enterprise market. According to The Information, AWS is considering selling its own networking switches to enterprise customers within the next 18 months. AWS is working with white-box manufacturers such as Celestica, Edgecore Networks and Delta Networks. AWS’ white’box […]

Dicerna Pharmaceuticals Doses First Patient with DCR-PHXC in Phase 1 Clinical Trial

Dicerna Pharmaceuticals Doses First Patient with DCR-PHXC in Phase 1 Clinical Trial

Dicerna Pharmaceuticals (DRNA) said Wednesday it has dosed the first primary hyperoxaluria (PH) patient with DCR-PHXC in a phase 1 clinical trial. DCR-PHXC is an investigational GalXC product candidate in development for the treatment of all forms of PH, a family of severe, rare, inherited disorders of the liver that often result in kidney failure. The company also announced that […]

Antares Pharma Receives Third Installment From Sale of ZOMAJET Device to Ferring

Antares Pharma Receives Third Installment From Sale of ZOMAJET Device to Ferring

Antares Pharma (ATRS) said pre-market Wednesday it has obtained $4.75 million from Ferring Pharmaceuticals in relation to the previously disclosed sale of Antares’ worldwide rights, including certain fixed assets for the ZOMAJET needle-free auto injector device to Ferring. The purchase price of up to $14.5 million was to be paid to Antares in four installments of which the first three […]

Daktronics Shares Slide 2.5% Pre-Bell

Daktronics Shares Slide 2.5% Pre-Bell

Daktronics (DAKT) shares were down 2.5% pre-market Wednesday after the supplier of large-screen video displays reported it swung to a fiscal Q4 loss on declining sales, missing Street expectations. For the quarter ended April 28, the company reported a net loss per share of $0.09, compared to a gain of $0.02 a year earlier, and below the Street view for […]

Titan Pharmaceuticals, Braeburn End License Agreement For Probuphine For Opioid Dependence

Titan Pharmaceuticals, Braeburn End License Agreement For Probuphine For Opioid Dependence

Titan Pharmaceuticals (TTNP) and pharmaceutical company Braeburn have agreed to terminate a license agreement that granted Braeburn exclusive rights to commercialize Probuphine, an opioid addiction treatment, in the US and Canada. Probuphine is a subdermal implant designed to deliver buprenorphine, an opioid used to treat opioid dependence, continuously for six months following a single treatment. Under the terms of the […]